Chase C. Leavitt Oncternal Therapeutics, Inc. (ONCT) insider trading activity

ONCT Quotes by TradingView

Chase C. Leavitt is General Counsel/Secretary of Oncternal Therapeutics, Inc.. Currently has a direct ownership of 84,758 shares of ONCT, which is worth approximately $96,624. The most recent transaction as insider was on Jan 03, 2024, when has been sold 11,838 shares (Common Stock) at a price of $0.5 per share, resulting in proceeds of $5,919. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84.8K
0% 3M change
12.26% 12M change
Total Value Held $96,624

Chase C. Leavitt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2024
SELL
Payment of exercise price or tax liability
$5,919 $0.5 p/Share
11,838 Reduced 12.26%
84,758 Common Stock
Jul 03 2023
SELL
Payment of exercise price or tax liability
$3,709 $0.36 p/Share
10,305 Reduced 9.64%
96,596 Common Stock
Apr 13 2023
BUY
Open market or private purchase
$2,900 $0.29 p/Share
10,000 Added 8.55%
106,901 Common Stock
Apr 12 2023
BUY
Open market or private purchase
$4,350 $0.29 p/Share
15,000 Added 13.4%
96,901 Common Stock
Jan 03 2023
SELL
Payment of exercise price or tax liability
$6,212 $1.02 p/Share
6,091 Reduced 6.92%
81,901 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
43,125 Added 32.89%
87,992 Common Stock
Jan 28 2022
BUY
Open market or private purchase
$8,150 $1.63 p/Share
5,000 Added 10.03%
44,867 Common Stock
Jan 27 2022
BUY
Open market or private purchase
$15,130 $1.78 p/Share
8,500 Added 17.57%
39,867 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
29,867 Added 48.78%
31,367 Common Stock
Jun 11 2021
BUY
Open market or private purchase
$8,175 $5.45 p/Share
1,500 Added 50.0%
1,500 Common Stock

Also insider at

LCTX
Lineage Cell Therapeutics, Inc. Healthcare
General Counsel/Secretary
CCL

Chase C. Leavitt

General Counsel/Secretary
San Diego, CA

Track Institutional and Insider Activities on ONCT

Follow Oncternal Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ONCT shares.

Notify only if

Insider Trading

Get notified when an Oncternal Therapeutics, Inc. insider buys or sells ONCT shares.

Notify only if

News

Receive news related to Oncternal Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ONCT